Long‐term outcome of the use of intravesical botulinum toxin for the treatment of overactive bladder (OAB) - Mohee, Amar; Khan, Ayisha; Harris, Neil; Eardley, Ian (BJU international, 2013)
Keywords: Administration, Intravesical; Biological and medical sciences; Botulinum Toxins, Type A - administration & dosage; Botulinum Toxins, Type A - adverse effects; detrusor overactivity; Female; Humans; intravesical botulinum toxin; Male; Medical sciences; Medication Adherence; Middle Aged; Nephrology. Urinary tract diseases; Neuromuscular Agents - administration & dosage; Neuromuscular Agents - adverse effects; OnabotulinumtoxinA; overactive bladder; Retrospective Studies; Treatment Outcome; Urinary Bladder, Neurogenic - drug therapy; Urinary Bladder, Overactive - drug therapy; Urinary Bladder, Overactive - etiology; Urinary system involvement in other diseases. Miscellaneous; Urinary tract. Prostate gland; Nephrology; Clostridium botulinum; Prognosis; Clostridiales; Metalloendopeptidases; Urology; Bontoxilysin; Urinary bladder; Bacteria; Overactive bladder; intravesical botulinum toxin; OnabotulinumtoxinA; Urinary system disease; Enzyme; detrusor overactivity; Urinary tract disease; Long term; Peptidases; Toxin; Treatment; Urinary system; Clostridiaceae; Hydrolases; Bladder disease; Intravesical administration